P1530: PERITRANFUSIONAL C1-INHIBITOR IN PATIENTS WITH SEVERE COMPLEMENT-MEDIATED AUTOIMMUNE HEMOLYTIC ANEMIA: AN OPEN LABEL PHASE 2 TRIAL.

por de Boer, E. C. W., Jalink, M., Delvasto-Nuñes, L., Meulenbroek, E. M., Baas, I., Janssen, S. R., Dijkman, E. E., Gelderman, K. A., Wouters, D., Engel, M. D., de Haas, M., Kersten, M.-J., Jongerius, I., Zeerleder, S., Vos, J. M.
Publicado 2022